CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
63.71
+1.41 (2.26%)
Jul 31, 2025, 11:47 AM - Market open
CVS Health Revenue
CVS Health had revenue of $98.92B in the quarter ending June 30, 2025, with 8.89% growth. This brings the company's revenue in the last twelve months to $385.34B, up 6.49% year-over-year. In the year 2024, CVS Health had annual revenue of $370.66B with 3.93% growth.
Revenue (ttm)
$385.34B
Revenue Growth
+6.49%
P/S Ratio
0.21
Revenue / Employee
$1,284,453
Employees
300,000
Market Cap
80.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 370.66B | 14.03B | 3.93% |
| Dec 31, 2023 | 356.62B | 34.99B | 10.88% |
| Dec 31, 2022 | 321.63B | 30.72B | 10.56% |
| Dec 31, 2021 | 290.91B | 23.00B | 8.59% |
| Dec 31, 2020 | 267.91B | 12.14B | 4.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 57.37B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
CVS News
- 1 hour ago - CVS Health Will Invest $20 Billion To Simplify US Health System, Delivers Strong Q2 Despite Legal Setbacks - Benzinga
- 1 hour ago - CVS Health Stock Surges After Earnings Smash Forecasts. A Value Play Has Become a Rally. - Barrons
- 2 hours ago - CVS Health Stock Soars on Strong Results, Raised 2025 Profit Outlook - Investopedia
- 3 hours ago - CVS stock jumps over 8% as turnaround fuels earnings beat, outlook raised - Invezz
- 4 hours ago - CVS Profits Eclipse $1 Billion As Aetna's Costs Begin To Stabilize - Forbes
- 4 hours ago - CVS's stock jumps, as profit beats by a wide margin and the outlook is raised - Market Watch
- 5 hours ago - CVS second-quarter profit beats estimates, helped by medical cost oversight - Reuters
- 5 hours ago - CVS beats estimates, hikes adjusted profit outlook on retail pharmacy and insurance unit strength - CNBC